SCHEMBL13768896

SCHEMBL13768896

CC1(C)CN(C(=O)Cc2ccc(N)nc2)CCN1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.47
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
GABRA2 P47869 1/20 0.46
GABRB2 P47870 1/20 0.46
GABRA4 P48169 1/20 0.46
GABRE P78334 1/20 0.46
GABRA6 Q16445 1/20 0.46
GABRG1 Q8N1C3 1/20 0.46
GABRG3 Q99928 1/20 0.46
GABRQ Q9UN88 1/20 0.46
NAMPT P43490 1/20 0.40
CPB1 P15086 2/20 0.38
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291376 0.86 GABRP (0.46) CDK4GABRPGABRDGABRA1GABRB1
SCHEMBL14084729 0.76 GABRP (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3318612 0.76 IDH1 (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20038223 0.74 VNN1 (0.39) CDK4PANK3SMN1; SMN2HSD11B1
SCHEMBL2234473 0.73 MAPT (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20038221 0.71 HSD11B1 (0.37) CDK4PANK3SMN1; SMN2HSD11B1CRBN
SCHEMBL20249346 0.71 PANK3 (0.37) CDK4PANK3SMN1; SMN2HSD11B1
SCHEMBL18291302 0.71 PANK3 (0.51) CDK4PANK3HSD11B1
SCHEMBL13769030 0.71 GABRP (0.48) CDK4GABRPGABRDGABRA1GABRB1
SCHEMBL20037975 0.69 SMN1; SMN2 (0.44) CDK4PANK3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085185-A1 FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS AMGEN INC. (US) 2009-07-09 WO disclosed